Tofacitinib

Live Zoster Vaccination Safe in RA Prior to Tofacitinib Initiation

Live Zoster Vaccination Safe in RA Prior to Tofacitinib Initiation

By

Herpes zoster vaccine shown to be safe in patients with rheumatoid arthritis.

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

By

Researchers found that one-third of patients remain in remission after discontinuing tofacitinib and that low baseline RF titers predict low disease activity after tofacitinib discontinuation.

Second Biologic Effective in Rheumatoid Arthritis After Initial Treatment Failure

Second Biologic Effective in Rheumatoid Arthritis After Initial Treatment Failure

By

Investigators conduct a systematic review to evaluate the risks and benefits of biologics as monotherapy or in combination with methotrexate in patients with rheumatoid arthritis who have not responded to previous biologic treatment.

Efficacy of JAK Monotherapy vs Combination Therapy in RA

Efficacy of JAK Monotherapy vs Combination Therapy in RA

By

Twelve-month trial compared tofacitinib with adalimumab as monotherapy or in combination with methotrexate.

New Clinical Trial Results: Safety and Efficacy of Tofacitinib in PsA

New Clinical Trial Results: Safety and Efficacy of Tofacitinib in PsA

Results were announced from a phase 3 trials assessing safety and efficacy of tofacitinib citrate for active psoriatic arthritis

Sign Up for Free e-newsletters